[New treatment methods in heart valve surgery--the Toronto SPV stentless bioprosthesis].
Stentless valves may be an alternative to conventional stented bioprostheses and homografts. From all tissue valves homografts proved to have the best long term results. But homografts are not always available. Stentless bioprostheses are similar to homografts concerning in implantation technique, valve anatomy and physiologic function. The stentless design leads to remodeling of the left ventricle and the aortic root, resulting in a superior hemodynamic profile. Nevertheless long term results are required.
Scheidt
A
A
Klinik und Poliklinik für Thorax-, Herz- und Gefässchirurgie, Univ. Göttingen.
Baryalei
M
M
Dalichau
H
H
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001022:Aortic Valve Insufficiency / Q000503:physiopathology / Q000601:surgery*; D001024:Aortic Valve Stenosis / Q000503:physiopathology / Q000601:surgery*; D001696:Biomechanical Phenomena; D001705:Bioprosthesis; D005260:Female; D006350:Heart Valve Prosthesis; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000503:physiopathology; D011474:Prosthesis Design; D016277:Ventricular Function, Left / Q000502:physiology
Neue Behandlungsverfahren in der Herzklappenchirurgie--Die Toronto SPV Stentlose Bioprothese.